194 related articles for article (PubMed ID: 15524047)
1. [Amorphization in pharmaceutical technology].
Révész P; Laczkovich O; Eros I
Acta Pharm Hung; 2004; 74(1):39-44. PubMed ID: 15524047
[TBL] [Abstract][Full Text] [Related]
2. Solid state amorphization of pharmaceuticals.
Willart JF; Descamps M
Mol Pharm; 2008; 5(6):905-20. PubMed ID: 18954076
[TBL] [Abstract][Full Text] [Related]
3. Formulation of tablets containing an 'in-process' amorphized active pharmaceutical ingredient.
Jójárt-Laczkovich O; Szabó-Révész P
Drug Dev Ind Pharm; 2011 Nov; 37(11):1272-81. PubMed ID: 21457129
[TBL] [Abstract][Full Text] [Related]
4. Hot-melt extrusion.
Jana S; Miloslava R
Ceska Slov Farm; 2012 Jun; 61(3):87-92. PubMed ID: 22913823
[TBL] [Abstract][Full Text] [Related]
5. [The applicability of sucrose laurate in hot-melt technology].
Lang P; Szuts A; Ambrus R; Szabóné RP
Acta Pharm Hung; 2011; 81(1):43-6. PubMed ID: 21595305
[TBL] [Abstract][Full Text] [Related]
6. Particle design of poorly water-soluble drug substances using supercritical fluid technologies.
Yasuji T; Takeuchi H; Kawashima Y
Adv Drug Deliv Rev; 2008 Feb; 60(3):388-98. PubMed ID: 18068261
[TBL] [Abstract][Full Text] [Related]
7. [Progress in the research of amorphous pharmaceuticals].
Ying J; Lü Y; Du GH
Yao Xue Xue Bao; 2009 May; 44(5):443-8. PubMed ID: 19618716
[TBL] [Abstract][Full Text] [Related]
8. Effect of wet milling process on the solid state of indomethacin and simvastatin.
Sharma P; Denny WA; Garg S
Int J Pharm; 2009 Oct; 380(1-2):40-8. PubMed ID: 19576976
[TBL] [Abstract][Full Text] [Related]
9. Understanding a relaxation behavior in a nanoparticle suspension for drug delivery applications.
Deng Z; Xu S; Li S
Int J Pharm; 2008 Mar; 351(1-2):236-43. PubMed ID: 18093763
[TBL] [Abstract][Full Text] [Related]
10. Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopy.
Heinz A; Strachan CJ; Gordon KC; Rades T
J Pharm Pharmacol; 2009 Aug; 61(8):971-88. PubMed ID: 19703341
[TBL] [Abstract][Full Text] [Related]
11. Industrially feasible alternative approaches in the manufacture of solid dispersions: a technical report.
Karanth H; Shenoy VS; Murthy RR
AAPS PharmSciTech; 2006 Oct; 7(4):87. PubMed ID: 17233539
[TBL] [Abstract][Full Text] [Related]
12. [Crystalline modifications and polymorphism changes during drug manufacture].
Doelker E
Ann Pharm Fr; 2002 May; 60(3):161-76. PubMed ID: 12050595
[TBL] [Abstract][Full Text] [Related]
13. Continuous processes for the production of pharmaceutical intermediates and active pharmaceutical ingredients.
LaPorte TL; Wang C
Curr Opin Drug Discov Devel; 2007 Nov; 10(6):738-45. PubMed ID: 17987525
[TBL] [Abstract][Full Text] [Related]
14. Density fluctuations in amorphous pharmaceutical solids. Can SAXS help to predict stability?
Laggner P; Paudel A
Colloids Surf B Biointerfaces; 2018 Aug; 168():76-82. PubMed ID: 29752132
[TBL] [Abstract][Full Text] [Related]
15. [The importance of micronization in the design of dosage forms II. Pharmaceutical technological considerations].
Antal I
Acta Pharm Hung; 2006; 76(3):149-54. PubMed ID: 17094663
[TBL] [Abstract][Full Text] [Related]
16. [Pharmaceutical significance of amorphous materials].
Antal I; Zelkó R
Acta Pharm Hung; 2008; 78(3):121-33. PubMed ID: 18986089
[TBL] [Abstract][Full Text] [Related]
17. Cyclodextrins as pharmaceutical solubilizers.
Brewster ME; Loftsson T
Adv Drug Deliv Rev; 2007 Jul; 59(7):645-66. PubMed ID: 17601630
[TBL] [Abstract][Full Text] [Related]
18. New QSPR study for the prediction of aqueous solubility of drug-like compounds.
Duchowicz PR; Talevi A; Bruno-Blanch LE; Castro EA
Bioorg Med Chem; 2008 Sep; 16(17):7944-55. PubMed ID: 18701302
[TBL] [Abstract][Full Text] [Related]
19. Use of calcined Mg-Al-hydrotalcite to enhance the stability of celecoxib in the amorphous form.
Ambrogi V; Perioli L; Marmottini F; Rossi C
Eur J Pharm Biopharm; 2007 May; 66(2):253-9. PubMed ID: 17123798
[TBL] [Abstract][Full Text] [Related]
20. Formation and physical stability of the amorphous phase of ranitidine hydrochloride polymorphs prepared by cryo-milling.
Chieng N; Rades T; Saville D
Eur J Pharm Biopharm; 2008 Mar; 68(3):771-80. PubMed ID: 17945474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
